These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 4566189

  • 1. Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth.
    Orfanos CE, Schaumburg-Lever G, Mahrle G, Lever WF.
    Arch Dermatol; 1973 Jan; 107(1):38-46. PubMed ID: 4566189
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the ultrastructure of psoriasis and of the "normal" skin of psoriatics.
    Nagy-Vezekényi C, Zs-Nagy I.
    Acta Derm Venereol; 1971 Jan; 51(6):435-43. PubMed ID: 4109424
    [No Abstract] [Full Text] [Related]

  • 3. Metabolic and ultrastructural studies in a patient with pustular psoriasis (von Zumbusch).
    Braverman IM, Cohen I, O'Keefe E.
    Arch Dermatol; 1972 Feb; 105(2):189-96. PubMed ID: 4334267
    [No Abstract] [Full Text] [Related]

  • 4. [Psoriasis].
    Guilhou JJ, Girard C.
    Rev Prat; 2006 Dec 15; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract] [Full Text] [Related]

  • 5. Psoriasis: current concepts in management.
    Hodge L, Comaish JS.
    Drugs; 1977 Apr 15; 13(4):288-96. PubMed ID: 324749
    [Abstract] [Full Text] [Related]

  • 6. Aspects of the Odland bodies in the synthesis of keratohyalin.
    Lagerholm B, Frithz A.
    Acta Derm Venereol; 1974 Apr 15; 54(5):359-64. PubMed ID: 4138189
    [No Abstract] [Full Text] [Related]

  • 7. The action of antimetabolites in the skin: methotrexate for psoriasis.
    Weinstein GD.
    Adv Biol Skin; 1972 Apr 15; 12():287-302. PubMed ID: 4579196
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical and pathophysiological rationale for amethopterin in psoriasis.
    Weinstein GD.
    Ann N Y Acad Sci; 1971 Nov 30; 186():452-66. PubMed ID: 5289429
    [No Abstract] [Full Text] [Related]

  • 9. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M, Gül M, Seyhan M.
    Ultrastruct Pathol; 2006 Nov 30; 30(1):95-102. PubMed ID: 16517475
    [Abstract] [Full Text] [Related]

  • 10. Psoriasis-liver-methotrexate interactions.
    Arch Dermatol; 1973 Jul 30; 108(1):36-42. PubMed ID: 4716740
    [No Abstract] [Full Text] [Related]

  • 11. [Membrane defect as a basic disorder of the growth control mechanism in psoriasis pathogenetic concept and therapeutic consequences (author's transl)].
    Orfanos CE, Mahrle G.
    Dermatologica; 1975 Jul 30; 151(4):199-215. PubMed ID: 178549
    [Abstract] [Full Text] [Related]

  • 12. The nature of psoriasis.
    Fry L.
    Br J Dermatol; 1968 Dec 30; 80(12):833-5. PubMed ID: 5706801
    [No Abstract] [Full Text] [Related]

  • 13. Chromosome aberrations in affected and unaffected skin of patients with psoriasis.
    Petersen GB, Christiansen JV, Voetmann E, Therkelsen AJ.
    Acta Derm Venereol; 1974 Dec 30; 54(2):147-51. PubMed ID: 4133021
    [No Abstract] [Full Text] [Related]

  • 14. Primary annular plaque-type psoriasis.
    Guill CL, Hoang MP, Carder KR.
    Pediatr Dermatol; 2005 Dec 30; 22(1):15-8. PubMed ID: 15660890
    [Abstract] [Full Text] [Related]

  • 15. Effects of methotrexate and hydroxyurea on psoriatic epidermis. Preferential cytotoxic effects on psoriatic epidermis.
    Smith C, Gelfant S.
    Arch Dermatol; 1974 Jul 30; 110(1):70-2. PubMed ID: 4418706
    [No Abstract] [Full Text] [Related]

  • 16. Biological and biochemical actions of methotrexate in psoriasis.
    Newburger AE, Weinstein GD, McCullough JL.
    J Invest Dermatol; 1978 Apr 30; 70(4):183-6. PubMed ID: 641369
    [No Abstract] [Full Text] [Related]

  • 17. Cell proliferation kinetics in benign and malignant skin diseases in humans.
    Weinstein GD, Frost P.
    Natl Cancer Inst Monogr; 1969 May 30; 30():225-46. PubMed ID: 5361648
    [No Abstract] [Full Text] [Related]

  • 18. Cellular changes in psoriatic and normal epidermis after treatment with ammonium mercuric chloride. Electron microscopy, tissue culture and neutron activation analyses.
    Frithz A.
    Acta Derm Venereol Suppl (Stockh); 1971 May 30; 51():Suppl 66:1-20. PubMed ID: 5284815
    [No Abstract] [Full Text] [Related]

  • 19. [Immunosuppressive drugs in the treatment of diseases belonging to the psoriasis group].
    Ruszczak Z.
    Pol Tyg Lek; 1974 Jun 17; 29(24):1051-3. PubMed ID: 4602505
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative study of the effect of the antimetabolic agent methotrexate in psoriasis, psoriatic arthropathy and rheumatoid arthritis].
    Siegmeth W, Eberl R, Tausch G, Raith W.
    Verh Dtsch Ges Rheumatol; 1969 Jun 17; 1():383-7. PubMed ID: 5403653
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.